← Back to headlines
Australian Regulator Warns of Rare Eye Disorder Linked to GLP-1 Drugs
Australia's Therapeutic Goods Administration (TGA) has issued a warning about a 'rare but severe' eye disorder, Non-Arteritic Ischemic Optic Neuropathy (NAION), linked to GLP-1 drugs such as Ozempic, updating product information for these medications.
24 Jul, 06:39 — 24 Jul, 06:39
